• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    Advancing Research with MtoZ Biolabs' Quantitative Glycoproteomics Service

      Quantitative glycoproteomics service is a powerful tool for precisely identifying and analyzing glycosylation modifications in glycoproteins. As a critical area within post-translational modification (PTM) research, quantitative glycoproteomics service is essential for understanding disease mechanisms, discovering biomarkers, developing novel drugs, and advancing personalized medicine.

       

      MtoZ Biolabs offers cutting-edge quantitative glycoproteomics service powered by Orbitrap Fusion mass spectrometry platforms. By utilizing both HCD and ETD fragmentation modes, combined with Byonic software, this service enables precise identification and quantification of N-linked and O-linked glycosylation sites. These capabilities allow researchers to uncover the functional implications of diverse glycosylation modifications on protein activity.

       

      Workflow of Quantitative Glycoproteomics Service

      The quantitative glycoproteomics service provided by MtoZ Biolabs is built upon cutting-edge mass spectrometry technology and a comprehensive service platform, ensuring the precise and efficient analysis of glycoprotein structures and functions. The workflow is outlined as follows:

      1. Sample Preparation

      The quality and purity of samples are pivotal to ensuring the reliability and accuracy of glycoproteomics analyses. MtoZ Biolabs employs rigorous quality control measures to ensure that samples meet the stringent requirements of mass spectrometry. Through optimized enzymatic digestion protocols, high-quality peptides are generated, ensuring the stability and reproducibility of downstream analyses.

       

      2. Labeling and Enrichment

      To enable high-throughput and multiplexed quantitative analyses, the platform supports the application of isotope labeling techniques such as iTRAQ and TMT. These methods label peptides after digestion and use advanced enrichment strategies to selectively capture glycosylated peptides, significantly enhancing the detection sensitivity for low-abundance glycoproteins and glycopeptides.

       

      3. LC-MS/MS Analysis

      Central to the quantitative glycoproteomics service is the precise analysis of glycopeptides using a nano-liquid chromatography (Nano-LC) system coupled with high-resolution Orbitrap Fusion series mass spectrometers. The combined application of HCD and ETD fragmentation modes ensures accurate structural elucidation of glycopeptides and precise identification of glycosylation sites.

       

      4. Data Processing and Identification

      MtoZ Biolabs' quantitative glycoproteomics service incorporates Byonic software for comprehensive mass spectrometry data analysis. This advanced tool enables accurate identification of glycosylation sites and quantification of N-linked and O-linked glycosylation patterns. Additionally, the service integrates multiple bioinformatics tools for an in-depth analysis, providing researchers with detailed and functional interpretations of their results.

       

      Applications

      The quantitative glycoproteomics service offered by MtoZ Biolabs is a powerful tool for uncovering the complex mechanisms of glycosylation and its biological roles. This advanced service enables researchers to address critical scientific and clinical challenges through applications such as:

      1. Disease Mechanism Research

      Glycosylation plays a central role in the pathogenesis of various major diseases, including cancer, diabetes, and neurodegenerative disorders. Quantitative analysis of glycoprotein modification patterns enables a deeper understanding of the molecular mechanisms driving disease initiation, progression, and metastasis.

       

      2. Biomarker Discovery

      The detection of disease-specific biomarkers is essential for advancing diagnostic and therapeutic approaches. The quantitative glycoproteomics service facilitates the identification of glycoproteins and their unique glycosylation patterns associated with specific diseases, providing robust evidence to support early diagnosis, targeted therapy, and effective therapeutic monitoring.

       

      3. Drug Development

      Protein glycosylation significantly impacts the activity, stability, and distribution of therapeutic targets, making it a critical focus in drug development. The quantitative glycoproteomics service offered by MtoZ Biolabs enables precise evaluation of glycosylation modifications, supporting the optimization of drug designs and enhancing both efficacy and safety in therapeutic development.

       

      4. Personalized Medicine

      In the era of precision medicine, quantitative glycoproteomics offers a comprehensive approach to personalized healthcare. Detailed profiling of glycoprotein modifications in patient samples enables accurate assessment of disease states, guiding the development of individualized treatment plans and improving clinical outcomes.

       

      Why Choose MtoZ Biolabs?

      Our primary advantages include:

      1. High-throughput Analysis Capability

      By leveraging iTRAQ/TMT labeling technologies, MtoZ Biolabs enables the simultaneous quantitative analysis of multiple samples, facilitating efficient high-throughput data acquisition.

       

      2. Large-scale Glycoproteomics Analysis

      This service supports extensive glycoproteomic analysis, including the detection of low-abundance proteins and peptides, ensuring both the breadth and depth necessary for comprehensive research outcomes.

       

      3. Advanced Analytical Platform

      MtoZ Biolabs utilizes state-of-the-art Orbitrap Fusion mass spectrometry, integrated with Nano-LC systems, to deliver analytical results with reliability, rapid throughput, and superior accuracy.

       

      4. One-Time-Charge

      Our pricing is transparent, no hidden fees or additional costs.

       

      5. High-Data-Quality

      Deep data coverage with strict data quality control. AI-powered bioinformatics platform integrates all quantitative glycoproteomics data, providing clients with a comprehensive data report.

       

      What Could Be Included in the Report?

      1. Comprehensive Experimental Details

      2. Materials, Instruments, and Methods

      3. Total Ion Chromatogram & Quality Control Assessment (project-dependent)

      4. Data Analysis, Preprocessing, and Estimation (project-dependent)

      5. Bioinformatics Analysis

      6. Raw Data Files

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

      Quantitative Glycoproteomics Service

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png